Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-10
2011-10-25
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S467000
Reexamination Certificate
active
08044088
ABSTRACT:
Compounds of general formula (I)wherein R1is halo or cyano;R2is C1-C4alkyl; andR3is phenyl substituted with one or more substituents chosen from C1-C6alkyl, halo or —SO2(C1-C6alkyl);or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; are useful in the treatment of diseases and conditions mediated by the action of PGD2at the CRTH2 receptor.
REFERENCES:
patent: 5641800 (1997-06-01), Bach et al.
patent: 6214991 (2001-04-01), Jones et al.
patent: 7534897 (2009-05-01), Tanimoto et al.
patent: 7582672 (2009-09-01), Middlemiss et al.
patent: 7750027 (2010-07-01), Armer et al.
patent: 2009/0018138 (2009-01-01), Middlemiss et al.
patent: 2009/0018139 (2009-01-01), Middlemiss et al.
patent: 2009/0018338 (2009-01-01), Middlemiss et al.
patent: 2009/0023788 (2009-01-01), Middlemiss et al.
patent: 2009/0192195 (2009-07-01), Armer et al.
patent: 2010/0022613 (2010-01-01), Armer et al.
patent: 2010/0035956 (2010-02-01), Armer et al.
patent: 2010/0041699 (2010-02-01), Boyd et al.
patent: 2010/0266535 (2010-10-01), Armer et al.
patent: 1 505 061 (2005-02-01), None
patent: 03/101981 (2003-12-01), None
patent: 2004/007451 (2004-01-01), None
patent: 2005/019171 (2005-03-01), None
patent: 2005/044260 (2005-05-01), None
patent: 2005/054232 (2005-06-01), None
patent: WO 2009/077728 (2009-06-01), None
Horig et al. Journal of Translational Medicine, 2:44 (2004).
Schafer et al. Drug Discovery Today, 13:913 (2008).
Uller et al. Respiratory Research, 8:16 (2007).
A.M. Rouhi, Chem. & Eng. News, 81:32 (Feb. 24, 2003).
Byrn et al. Solid-State Chemistry of Drugs, 2d, Chapter 11 Hydrates and Solvates, 233-247 (1999).
Morissette et al., Adv. Drug Delivery Rev., 56:275 (2004).
Grant & Hackh's Chemical Dictionary (5th ed. McGraw-Hill, Inc., 1987).
Unpublished U.S. Appl. No. 12/779,638, filed May 13, 2010; inventors: Hunter et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Unpublished U.S. Appl. No. 13/014,314, filed Jan. 26, 2011; inventors: Armer et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Unpublished U.S. Appl. No. 13/017,860, filed Jan. 31, 2011; inventors: Armer et al., U.S. Patent and Trademark Office, Alexandria, Virginia.
Armer Richard Edward
Boyd Edward Andrew
Boyd, legal representative Judith Helen
Hay Philip Andrew
Barker Michael
Chu Yong
Oxagen Limited
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
1-acetic acid-indole derivatives with PGD2 antagonist activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-acetic acid-indole derivatives with PGD2 antagonist activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-acetic acid-indole derivatives with PGD2 antagonist activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4256432